Osimertinib 40mg tablets
NHS hospitals in England used £38,560,120 of indicative cost of Osimertinib 40mg tablets in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is up 10.0% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Osimertinib 40mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Osimertinib 40mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Royal Surrey County Hosp Nhs Found Trust | £1,953,337 |
| The Royal Marsden Nhs Foundation Trust | £1,865,805 |
| The Christie Nhs Foundation Trust | £1,642,334 |
| Manchester University Nhs Ft | £1,459,810 |
| Royal Free London Nhs Foundation Trust | £1,359,412 |
| Southend Univ Hosp Nhs Foundation Trust | £1,323,061 |
| Western Sussex Hospitals Nhs Found Trust | £1,087,453 |
| University Hpls Of Leicester Nhs Trust | £1,069,758 |
| Univ Hpls Bristol Nhs Foundation Trust | £858,576 |
| Barts Health Nhs Trust | £839,343 |
The primary-care picture
Osimertinib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Osimertinib medicine page.